118 related articles for article (PubMed ID: 37398283)
1. Musashi-2 (MSI2) regulation of DNA damage response in lung cancer.
Bychkov I; Deneka A; Topchu I; Pangeni RP; Lengner C; Karanicolas J; Golemis EA; Makhov P; Boumber Y
bioRxiv; 2023 Jun; ():. PubMed ID: 37398283
[TBL] [Abstract][Full Text] [Related]
2. Musashi-2 (MSI2) regulation of DNA damage response in lung cancer.
Bychkov I; Deneka A; Topchu I; Pangeni R; Ismail A; Lengner C; Karanicolas J; Golemis E; Makhov P; Boumber Y
Res Sq; 2024 Apr; ():. PubMed ID: 38659828
[TBL] [Abstract][Full Text] [Related]
3. Musashi-2 (MSI2) regulates epidermal growth factor receptor (EGFR) expression and response to EGFR inhibitors in EGFR-mutated non-small cell lung cancer (NSCLC).
Makhov P; Bychkov I; Faezov B; Deneka A; Kudinov A; Nicolas E; Brebion R; Avril E; Cai KQ; Kharin LV; Voloshin M; Frantsiyants E; Karnaukhov N; Kit OI; Topchu I; Fazliyeva R; Nikonova AS; Serebriiskii IG; Borghaei H; Edelman M; Dulaimi E; Golemis EA; Boumber Y
Oncogenesis; 2021 Mar; 10(3):29. PubMed ID: 33723247
[TBL] [Abstract][Full Text] [Related]
4. Musashi-2 (MSI2) supports TGF-β signaling and inhibits claudins to promote non-small cell lung cancer (NSCLC) metastasis.
Kudinov AE; Deneka A; Nikonova AS; Beck TN; Ahn YH; Liu X; Martinez CF; Schultz FA; Reynolds S; Yang DH; Cai KQ; Yaghmour KM; Baker KA; Egleston BL; Nicolas E; Chikwem A; Andrianov G; Singh S; Borghaei H; Serebriiskii IG; Gibbons DL; Kurie JM; Golemis EA; Boumber Y
Proc Natl Acad Sci U S A; 2016 Jun; 113(25):6955-60. PubMed ID: 27274057
[TBL] [Abstract][Full Text] [Related]
5. Regulation of VEGFR2 and AKT Signaling by Musashi-2 in Lung Cancer.
Bychkov I; Topchu I; Makhov P; Kudinov A; Patel JD; Boumber Y
Cancers (Basel); 2023 Apr; 15(9):. PubMed ID: 37173995
[TBL] [Abstract][Full Text] [Related]
6. Regulation of VEGFR2 and AKT signaling by Musashi-2 in lung cancer.
Bychkov I; Topchu I; Makhov P; Kudinov A; Patel JD; Boumber Y
bioRxiv; 2023 Mar; ():. PubMed ID: 37034813
[TBL] [Abstract][Full Text] [Related]
7. Musashi 2 (MSI2) expression as an independent prognostic biomarker in non-small cell lung cancer (NSCLC).
Topchu I; Karnaukhov N; Mazitova A; Yugai V; Voloshin M; Tikhomirova M; Kit O; Frantsiyants E; Kharin L; Airapetova T; Ratner E; Sabirov A; Abramova Z; Serebriiskii I; Boumber Y; Deneka A
J Thorac Dis; 2021 Mar; 13(3):1370-1379. PubMed ID: 33841930
[TBL] [Abstract][Full Text] [Related]
8. Musashi-2 in cancer-associated fibroblasts promotes non-small cell lung cancer metastasis through paracrine IL-6-driven epithelial-mesenchymal transition.
Samart P; Heenatigala Palliyage G; Issaragrisil S; Luanpitpong S; Rojanasakul Y
Cell Biosci; 2023 Nov; 13(1):205. PubMed ID: 37941042
[TBL] [Abstract][Full Text] [Related]
9. MUSASHI-2 confers resistance to third-generation EGFR-tyrosine kinase inhibitor osimertinib in lung adenocarcinoma.
Yiming R; Takeuchi Y; Nishimura T; Li M; Wang Y; Meguro-Horike M; Kohno T; Horike SI; Nakata A; Gotoh N
Cancer Sci; 2021 Sep; 112(9):3810-3821. PubMed ID: 34145929
[TBL] [Abstract][Full Text] [Related]
10. Musashi-2 Deficiency Triggers Colorectal Cancer Ferroptosis by Downregulating the MAPK Signaling Cascade to Inhibit HSPB1 Phosphorylation.
Meng X; Peng X; Ouyang W; Li H; Na R; Zhou W; You X; Li Y; Pu X; Zhang K; Xia J; Wang J; Zhuang G; Tang H; Peng Z
Biol Proced Online; 2023 Dec; 25(1):32. PubMed ID: 38041016
[TBL] [Abstract][Full Text] [Related]
11. Developmental expression of Musashi-1 and Musashi-2 RNA-binding proteins during spermatogenesis: analysis of the deleterious effects of dysregulated expression.
Sutherland JM; Fraser BA; Sobinoff AP; Pye VJ; Davidson TL; Siddall NA; Koopman P; Hime GR; McLaughlin EA
Biol Reprod; 2014 May; 90(5):92. PubMed ID: 24671879
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-143 acts as a tumor suppressor through Musashi-2/DLL1/Notch1 and Musashi-2/Snail1/MMPs axes in acute myeloid leukemia.
Li F; Han Y; Chen R; Jiang Y; Chen C; Wang X; Zhou J; Xu Q; Jiang S; Zhang S; Yu K; Zhang S
J Transl Med; 2023 May; 21(1):309. PubMed ID: 37149661
[TBL] [Abstract][Full Text] [Related]
13. Small Molecule Palmatine Targeting Musashi-2 in Colorectal Cancer.
Zhang X; Su K; Liu Y; Zhu D; Pan Y; Ke X; Qu Y
Front Pharmacol; 2021; 12():793449. PubMed ID: 35153752
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-143/Musashi-2/KRAS cascade contributes positively to carcinogenesis in human bladder cancer.
Tsujino T; Sugito N; Taniguchi K; Honda R; Komura K; Yoshikawa Y; Takai T; Minami K; Kuranaga Y; Shinohara H; Tokumaru Y; Heishima K; Inamoto T; Azuma H; Akao Y
Cancer Sci; 2019 Jul; 110(7):2189-2199. PubMed ID: 31066120
[TBL] [Abstract][Full Text] [Related]
15. RNA-binding protein MSI2 isoforms expression and regulation in progression of triple-negative breast cancer.
Li M; Li AQ; Zhou SL; Lv H; Wei P; Yang WT
J Exp Clin Cancer Res; 2020 May; 39(1):92. PubMed ID: 32448269
[TBL] [Abstract][Full Text] [Related]
16. Cooperation of Musashi-2, Numb, MDM2, and P53 in drug resistance and malignant biology of pancreatic cancer.
Sheng W; Dong M; Chen C; Wang Z; Li Y; Wang K; Li Y; Zhou J
FASEB J; 2017 Jun; 31(6):2429-2438. PubMed ID: 28223335
[TBL] [Abstract][Full Text] [Related]
17. Musashi-2 is a novel regulator of paclitaxel sensitivity in ovarian cancer cells.
Lee J; An S; Choi YM; Lee J; Ahn KJ; Lee JH; Kim TJ; An IS; Bae S
Int J Oncol; 2016 Nov; 49(5):1945-1952. PubMed ID: 27600258
[TBL] [Abstract][Full Text] [Related]
18. Integrative genome-wide analysis reveals EIF3A as a key downstream regulator of translational repressor protein Musashi 2 (MSI2).
Karmakar S; Ramirez O; Paul KV; Gupta AK; Kumari V; Botti V; de Los Mozos IR; Neuenkirchen N; Ross RJ; Karanicolas J; Neugebauer KM; Pillai MM
NAR Cancer; 2022 Jun; 4(2):zcac015. PubMed ID: 35528200
[TBL] [Abstract][Full Text] [Related]
19. Suppression of Musashi‑2 by the small compound largazole exerts inhibitory effects on malignant cells.
Wang M; Sun XY; Zhou YC; Zhang KJ; Lu YZ; Liu J; Huang YC; Wang GZ; Jiang S; Zhou GB
Int J Oncol; 2020 May; 56(5):1274-1283. PubMed ID: 32319553
[TBL] [Abstract][Full Text] [Related]
20. The Novel KLF4/MSI2 Signaling Pathway Regulates Growth and Metastasis of Pancreatic Cancer.
Guo K; Cui J; Quan M; Xie D; Jia Z; Wei D; Wang L; Gao Y; Ma Q; Xie K
Clin Cancer Res; 2017 Feb; 23(3):687-696. PubMed ID: 27449499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
